Neurological aspects of urinary incontinence in the elderly
Abstract
The paper gives data on the prevalence, pathogenesis, and treatment of urinary incontinence in the elderly. There is a high rate of urinary incontinence among the patients who have experienced stroke or suffer from dementia or other neurological diseases. The ideas on the pathogenesis and manifestations of overactive bladder, stress urinary incontinence are outlined. Currently available drugs (anticholinergics, antidepressants, botulinum toxin preparations), methods for behavioral therapy and physiotherapy, and skin care in urinary incontinence are discussed. The current treatment options can improve quality of life in the elderly and their milieu.
References
1. <div><p>Пушкарь Д.Ю. Гиперактивный мочевой пузырь у женщин. М.: МедПрессИнформ, 2003; 160 с.</p><p>Мазо Е.Б., Кривобородов Г.Г. Неврологический аспект синдрома гиперактивного мочевого пузыря. Журн неврол и психиатр 2005;7:58-62.</p><p>Weltz-Barth A. Inkontinenz im Alter, ein soziales und Ö konomisches Problem Urologe 2007;46:363-4.</p><p>Roe B., Flanagan L., Jack B. Systematic review of the management of incontinence and promotion of continence in older people in care homes: descriptive studies with urinary incontinence as primary focus. J Advanc Nursing 2010;67(2):228—50.</p><p>Leung F.W., Schnelle J.F. Urinary and Fecal Incontinence in Nursing Home Residents. Gastroenterol Clin North Am 2008;37:697.</p><p>Abrams P., Wein A.J. The overactive bladder: A widespread but treatable condition. Stockholm, Sparre Medical Group, 1998.</p><p>Wernecke J, Dreyer M. Patienten mit Diabetes mellitus im Altenpflegeheim. Eur J Geriatr 2003;5:123-27.</p><p>Lifford K.L., Curham G.C., Hu F.R. et al. Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc 2005;53:1851-7.</p><p>Lai H., Boone T., Appell R. Selecting a medical therapy for overactive bladder. Rev Urol 2002;4:28-37.</p><p>Cerruto M.A. , Asimakopoulos A.D., Artibani W. et al. Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity. Urol Int 2012;89:1-8.</p><p>Lipton R.B., Kolondner K., Wesnes K. Assessment ot cognitiv function of the elderly population: effects of darifenacine. J Urol 2005;173:493-8.</p><p>Goepel M., Kirschner-Hermanns R., WelzBarth A. et al. Urinary Incontinence in the Elderly. Dtsch Arztebl Int 2010;107(30):531-6.</p><p>Norton P.A., Zinner N.R., Yalcin I., Bump R.C. Duloxetine vs. Placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40-8.</p><p>Apostolidis A., Dasgupta P., Denys P. et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2009;55:100-20.</p><p>Dumoulin C., Hay-Smith J. Pelvic floor muscle training versus no treatment for urinary incontinence in women. A Cochrane systematic review. Eur J Phys Rehabil Med 2008;44:47.</p><p>Воробьев П.А., Краснова Л.С., Шустов А.Г. и др. Клинико-экономический анализ эффективности использования подгузников MoliCare® Premium extra soft (Моликар Премиум экстра софт) для профилактики развития дерматита и пролежней у неподвижных больных с недержанием мочи. В сб.: Пролежни. Экономика и профилактика. Под ред. П.А. Воробьева, Л.С. Красновой. М.: Ньюдиамед, 2012; 34-99.</p></div><br />
Review
For citations:
Parfenov V.A. Neurological aspects of urinary incontinence in the elderly. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(1):34-38. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2395
Views: 2552
Email this article 